Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine
The solvent-shift method was used to identify appropriate polymers that inhibit the growth of felodipine crystals by monitoring particle size in supersaturated drug solutions in the presence of different polymers. We speculated that there would be an intermolecular interaction between the selected polymer (zein) and felodipine by extrapolating the inhibitory effect on crystal growth and then used the selected polymer as a carrier to prepare solid dispersions. The formulations were characterized by crystalline properties, thermodynamics of mixing, dissolution behavior, and physical stability. Powder x-ray diffraction and differential scanning calorimetry experiments indicated that amorphous solid dispersions were formed when the proportion of felodipine was < 30% (w/w). Stability tests showed that a solid dispersion with 20% felodipine remained in an amorphous state and was stable under accelerated storage conditions for 6 months. The dissolution rates of solid dispersions were significantly greater than those of the active pharmaceutical ingredient or physical mixtures. Analysis by Fourier-transform infrared spectroscopy and Raman microspectroscopy indicated the formation of intermolecular interactions between zein and felodipine. The study demonstrates the successful application of the chosen polymer as a carrier in solid dispersions and validates the concept of extrapolating the inhibitory effect on crystal growth to intermolecular interactions.
KEY WORDSfelodipine zein inhibitory effect on crystal growth solid dispersions intermolecular interactions
This work was supported by the Baoshan District Committee of Science and Technology (grant no. bkw2014131) and the National Natural Science Foundation of China (grant no. 21576080).
Compliance with Ethical Standards
Disclosure of Interest
The authors report no conflicts of interest.
- 10.Sun M, Wu C, Qiang F, Di D, Kuang X, Wang C, et al. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. Int J Pharm. 2016;503(1–2):238–46. https://doi.org/10.1016/j.ijpharm.2016.01.062.CrossRefGoogle Scholar
- 17.Kaushik S, Pathak K. Solvent wetting method—a novel approach for preparation of felodipine solid dispersion. Int J Pharm Sci Lett. 2012;2(6):163–6.Google Scholar
- 20.Olabisi O, Robeson LM, Shaw MT. Polymer–polymer miscibility. New York: Academic Press; 1979.Google Scholar
- 22.Rubinstein M, Marsac PJ. Polymer physics. New York: Oxford University Press; 2003.Google Scholar
- 23.Iskandar M, Krause S. Phase separation in styrene-a-methyl styrene block copolymers. Polym alloys Polym Sci Technol. 1978;10:231–43.Google Scholar
- 27.Tung NT, Hung MV, Vo XM, Nguyen TH, Pham TMH. Formulation optimization of orally disintegrating tablets containing solid dispersion of felodipine and hydroxypropyl methylcellulose using face-centered central composite design. J Pharm Investig. 2014;44(2):111–8. https://doi.org/10.1007/s40005-013-0106-z.CrossRefGoogle Scholar